Affiliation:
1. Departamento Producción y Sanidad Animal, Salud Pública y Ciencia y Tecnología de los Alimentos, Facultad de Veterinaria, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain
Abstract
Canine malignant lymphoma is a common neoplasia in dogs, and some studies have used dogs as a research model for molecular mechanisms of lymphomas in humans. In two species, chemotherapy is the treatment of choice, but the resistance to conventional anticancer drugs is frequent. The knowledge of molecular mechanisms of development and progression of neoplasia has expanded in recent years, and the underlying epigenetic mechanisms are increasingly well known. These studies open up new ways of discovering therapeutic biomarkers. Histone deacetylases and demethylase inhibitors could be a future treatment for canine lymphoma, and the use of microRNAs as diagnosis and prognosis biomarkers is getting closer. This review summarises the epigenetic mechanisms underlying canine lymphoma and their possible application as treatment and biomarkers, both prognostic and diagnostic.
Subject
General Veterinary,Animal Science and Zoology
Reference169 articles.
1. Canine Neoplasia in the UK: Estimates of Incidence Rates from a Population of Insured Dogs;Dobson;J. Small Anim. Pract.,2002
2. Breed Prevalence of Canine Lymphoma in South Africa;Hooijberg;J. S. Afr. Vet. Assoc.,2018
3. Distinct B-Cell and T-Cell Lymphoproliferative Disease Prevalence among Dog Breeds Indicates Heritable Risk;Modiano;Cancer Res.,2005
4. Comazzi, S., Marelli, S., Cozzi, M., Rizzi, R., Finotello, R., Henriques, J., Pastor, J., Ponce, F., Rohrer-Bley, C., and Rütgen, B.C. (2018). Breed-Associated Risks for Developing Canine Lymphoma Differ among Countries: An European Canine Lymphoma Network Study. BMC Vet. Res., 14.
5. Classification of Canine Malignant Lymphomas According to the World Health Organization Criteria;Valli;Vet. Pathol.,2011
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献